Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
2.320
-0.180 (-7.20%)
May 13, 2025, 4:00 PM - Market closed
Mereo BioPharma Group Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
36
Market Cap
368.88M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
MREO News
- 23 hours ago - Mereo BioPharma Reports First Quarter 2025 Financial Results and Provides Corporate Highlights - GlobeNewsWire
- 6 weeks ago - Mereo BioPharma Reports Full Year 2024 Financial Results and Provides Corporate Highlights - GlobeNewsWire
- 2 months ago - Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Healthcare Conference - GlobeNewsWire
- 4 months ago - Mereo BioPharma Provides Update on Lead Clinical Programs - GlobeNewsWire
- 4 months ago - Mereo BioPharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 6 months ago - Mereo BioPharma: Setrusumab Chugs Along With Possible Inflection Points - Seeking Alpha
- 6 months ago - Mereo BioPharma to Participate in Fireside Chat at the Jefferies London Healthcare Conference - GlobeNewsWire
- 6 months ago - Mereo BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire